Bank Norwegian AS
Reference is made to previous announcements regarding MREL and the decision from the Board of Directors to apply to the Norwegian Financial Supervisory Authority (FSA) to merge Norwegian Finans Holding ASA and Bank Norwegian AS. The Norwegian FSA has on 5 January 2021 approved an application on the new company structure, leaving Bank Norwegian AS the ultimate parent company of the group after a merger. We are pleased to have received this approval, as a merger is expected to give positive synergies on administrative costs as well as reduce funding cost on future MREL eligible capital being issued from an operating company instead of a holding company.
Based on the approval, Norwegian Finans Holding ASA and Bank Norwegian AS will move forward with the formal merger process, including preparing the necessary documentation, applications and decisions by the companies’ governing bodies.
The ambition is to complete the merger process during first half of 2021, with accounting and fiscal effect from 1 January 2021, conditional on obtaining necessary approvals from relevant authorities.
Contact persons:
CFO Klara Lise Aasen; phone +47 47635583; kaa@banknorwegian.no
Head of Treasury Mats Benserud; phone +47 95891539; mbe@banknorwegian.no
This information is subject to the disclosure requirements pursuant to Section 5-12 the Norwegian Securities Trading Act
To view this piece of content from www.globenewswire.com, please give your consent at the top of this page.To view this piece of content from ml-eu.globenewswire.com, please give your consent at the top of this page.
About Globenewswire
Subscribe to releases from Globenewswire
Subscribe to all the latest releases from Globenewswire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Globenewswire
Novo Nordisk A/S21.6.2025 01:38:10 CEST | Press release
Novo Nordisk: Higher dose of Wegovy® provided average weight loss of 21% in people with obesity – with a third achieving 25% or more – according to data presented at ADA
Novo Nordisk A/S21.6.2025 01:34:39 CEST | Press release
Novo Nordisk’s subcutaneous and oral amycretin data published in The Lancet and presented at ADA 2025
Meeting Professionals International (MPI)21.6.2025 01:30:16 CEST | Press release
MPI Shares WEC 2025 Highlights, Announces Strategic Growth and New Offerings at Annual Press Conference
Leading Edge Materials Corp.20.6.2025 23:30:00 CEST | Press release
LEADING EDGE MATERIALS REPORTS QUARTERLY RESULTS TO APRIL 30, 2025
Aduro Clean Technologies Inc.20.6.2025 22:33:57 CEST | Press release
Aduro Clean Technologies Announces Closing of Underwriter’s Over-Allotment Option in Public Offering
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom